863O - Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results
| Autor: | Gross-Goupil, M., Kwon, T.G., Eto, M., Ye, D., Miyake, H., Seo, S.I., Byun, S.S., Lee, J.L., Master, V., Jin, J., Debenedetto, R., Linke, R., Casey, M., Rosbrook, B., Lechuga Frean, M.J., Valota, O., Grande, E., Quinn, D.I. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|